With earnings season now hitting a full swing, the opportunities really start to pop.
- Here's a Juicy Earnings Season Play for You
- What Wall Street Gets Wrong About This "Kind-Of Rally"
- What Every Investor Should Know About Canopy Right Now
- Here's the Sector That Will Affect Markets the Most This Week
- Here Are the Cannabis Earnings Reports I'm Watching in This Big Revenue Quarter
- The Earnings Every Investor Should Watch This Week
- Here's What's Really Happening with Aphria's Stellar Earnings Report
- Here’s the Truth About Those Big Bank Earnings Beats
- How to Bank the Biggest Possible Gains in the Market Today
- This Earnings Season’s Winners Could Put Money in Your Pocket for Years to Come
- Constellation Brand’s Earnings Report Shows Why It’s the Perfect Time to Buy
- Investing in This Sector Could Be the Biggest Mistake of Your Life
- How to Play the Two Biggest Earnings Reports This Week
- Here Are the Most Important Earnings Reports to Watch This Week
- Buy These Explosive Earnings Season Standouts Before Today's Close
- The Shockingly Tiny Earnings Number That Could Shift the Entire Market
The Dow and S&P 500 both broke three-week losing streaks last week, and the Nasdaq Composite was up for the second week in a row.
We're heading back up closer to all-time highs.
So why do I say this is just a "kind-of rally" with all this seemingly good news?
Last week was an otherwise down week if not for the one positive lifting market on Friday: trade talks.
This was good news, until it was stripped down and re-rated by market judges.
The United States looked like it scored a victory because China agreed to purchase $40 billion to $50 billion in U.S. agricultural products, at least according to the White House, but the time frame of any purchases wasn't immediately clear.
Also, China agreed to open its market to international financial services, again according to the White House. Trump, potentially allowing U.S. banks and insurance companies to expand in China: no timetable there either.
China looks like it scored on account of the United States not moving forward on Oct. 15 with a planned increase in tariff rates to 30% from 25% on about $250 billion of Chinese goods.
Canopy Growth disappointed investors with its quarterly earnings. In fact, investors were so "disappointed" by this one report they sent the entire cannabis sector tumbling.
That's the thing: Canopy's results mean essentially nothing at all for American marijuana companies - nothing for any company outside Canada, in fact.
It's no different than if, say, California-based PG&E shares tanked because Consolidated Edison had a power failure in New York City.
But we're still in the early stages of legal cannabis' explosive growth potential.
Canopy led the sector down because investors are expecting results yesterday. And the results can be longer in coming than short-sighted investors might like.
Our Technical Trading Specialist is continuing to keep a close watch on the markets for the week ahead, including the most impactful earnings reports and sector that will act as a bellwether for the broader economy…
The past few months have seen some minor scandals push marijuana shares’ prices down, which is natural in a new industry like this.
Aphria, however, zoomed to an intraday high of $7.45 after announcing earnings.
The company increased its net cannabis revenue by 85%, which is a big deal – and it won’t be the only cannabis firm to do that.
Our Technical Trading Specialist is looking at all the big earnings plays ahead during this crucial week for the markets as earnings season comes to a close.
Aphria reported its fiscal fourth-quarter earnings last week, and the company exceeded all expectations.
And it beat those estimates from underneath a cloud of short sellers' spurious innuendo, to boot.
After a quarter of overall decline in Canadian cannabis revenue, Aphria saw an increase of 85% - that's 85% sequentially and not year over year. The company also turned earnings before interest, tax, depreciation, and amortization (EBITDA) positive - albeit after adjustments and with help from a European pharmaceutical distribution business the company owns.
And to top it off, management's optimistic about the future.
So any investor could look at Aphria's reporting and conclude it had a great quarter. And they'd be dead on.
What might not be so obvious at first glance is that this company just showed investors how it was going to take the cannabis sector to the next level.
Earnings season is now in high gear, and as I predicted last week, the numbers are coming in stronger than the pundits expected.
That was definitely the case with the big banks last week; Goldman Sachs blew the doors off Wall Street's expectations, posting earnings of $5.81 versus the $4.89 analysts had on the board. JPMorgan posted earnings of $2.82 versus estimates of $2.50.
JPMorgan's CEO, Jamie Dimon, noted "positive momentum with the U.S. consumer - healthy confidence levels, solid job creation, and rising wages."
Now, it's certainly true the consumer is stronger than the headlines suggest. That's a truth we talk about frequently.
But that's not the real story...
The truth is something you and I and just about every American know deep down: There are some significant challenges facing U.S. consumers right now.
I'm talking about very real inflation - the existence of which the Fed has denied for years now - and the ever-increasing levels of consumer debt out there.
The two are related, despite what you might hear coming out of Washington and Wall Street.
We've had a few "appetizers," but the full earnings season is here now.
These reports can make traders and investors really anxious, when they hope they've bought the right stock, or put on the right trade with calls or puts.
Trouble is, moving ahead of an earnings release and hoping things simply break your way is the absolute worst way to be in the markets. You can lose your shirt, and chances are you will.
But when you play it right with the Money Calendar, like you'll see in the video I'm about to show you, all that anxiety turns to excitement... over what you're going to do with all the extra cash. You'll sleep better, too - believe me.
Why? Because this method slashes your risk to a minimum, even as it boosts your potential for profits.
Well, believe it or not, Q2 earnings season is upon us – and it’s widely expected to be a downer.
With the average decline in earnings coming in around 2.6%, it’ll be the second straight quarter of declines year over year.
By comparison, the average estimated earnings decline was just 0.5%, so this is potentially a big deal.
Constellation Brands Inc. (NYSE: STZ) has grown 20% in the last six months, and Wall Street projects it will grow another 46% with a high target of $288.
That’ll register as 66% growth for 2019.
But there’s plenty of reason to believe this projection is not generous enough.
Wall Street has shown, on multiple occasions, that it does not fully appreciate the growth potential of Constellation Brands.
Some shady financial practices have inflated the stock prices in this sector, but this one strategy weeds out the sick companies from the healthy.
It's another huge week of earnings reports with 27% of the S&P 500 companies releasing their reports.
Chief among them are two of the world's largest companies by market capitalization - Alphabet Inc./Google (GOOGL) and Apple Inc. (AAPL).
Investors will have their attention fixed on these two behemoths, as their performance will almost certainly help dictate whether the market continues to climb, or we see a fall back below the new intraday high we saw this week.
Get this - the big cap tech companies all exceeded expectations, helping drive the S&P 500 to fresh all-time highs.
And it's nowhere close to being over.
In fact we're at the start of the second-busiest reporting week of the season, with 135 of S&P companies scheduled to report.
This earnings season, there are dozens upon dozens of companies heading higher in a hurry.
In fact, Chris is going to tell you about not one, but two that are up for grabs.